Baxter International : Scholars Award Winners Announced
September 17, 2021 at 10:12 am EDT
Share
To help increase representation in healthcare and expand the pipeline of Black healthcare professionals, we've awarded the first health and science scholarships to two Tennessee State University students through our Activating Change Today initiative.
Tennessee State University (TSU) students Camille Haskins and George Pickens are the inaugural recipients of the Baxter Scholars Award, a program established as part of our recent commitment to fund $1.2 million in scholarships and grants to expand the pipeline of Black students in health and sciences fields at three historically Black Colleges and Universities (HBCUs).
A component of Baxter's ACT: Activating Change Today initiative, two students a year for the next three years will receive $135,000 each while enrolled in the Dr. Levi Watkins, Jr. Medical, Dental and Accelerated Pathway Program, a shared program between TSU and Meharry Medical College. The accelerated pipeline program prepares qualified TSU students for early acceptance to Meharry, where students will spend three years in pre-medical courses of study at TSU before being admitted to and enrolling at Meharry to study medicine or dentistry. The Pathway Program participants will complete their undergraduate and medical school studies in seven years, instead of the customary eight years.
Camille Haskins
Camille Haskins grew up in Prince George's County, Maryland, home to one of the strongest and most prosperous Black communities in the United States.
Camille was fortunate to have been raised in a community where Black doctors, teachers, and leaders were the norm; her upbringing has instilled in her both a passion for education and a strong sense of determination that she will pass on to others.
Throughout her career in medicine, Camille wants to impart trust and confidence in medicine to underserved communities. More importantly, Camille would like to pass on the benefit of having Black mentors to the next generation in order to encourage change and racial justice in underserved communities around the U.S.
Camille feels honored to be part of the inaugural class of the Dr. Levi Watkins program and is eager to begin her journey to a career in medicine and her role as a leader.
George Pickens, IV
George Pickens IV is from Miami, Florida and is a current TSU student.
An active member in academic and community-building pursuits, George spearheads symposiums geared towards combating mental health issues in underserved communities and mending relationships between youth and law enforcement.
George has a keen interest in the sciences and has a devout passion for assisting others daily. In the future, he plans to become a family care physician coupled with research to identify the correlation between race and certain diseases. He also plans on providing affordable healthcare to marginalized communities.
Congratulations to Camille and George on receiving the inaugural Baxter Scholars Award and thank you for the meaningful impact you are contributing to the communities you serve.
Baxter Scholars Award
Learn about our commitment to expand the pipeline of black students in health and sciences fields.
Learn More
Activating Change Today
Learn about our multi-year initiative to advance racial justice.
Learn More
Corporate Responsibility
We strive to create lasting value by empowering our patients, protecting our planet and championing our people and communities.
Learn More
Attachments
Original document
Permalink
Disclaimer
Baxter International Inc. published this content on 17 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 September 2021 14:11:07 UTC.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows:
- medicines and medical devices (33.8%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.);
- kidney dialysis drugs and equipment (30.1%);
- systems for delivering medications and intravenous therapy (15.2%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc.;
- other (20.1%).
Export accounts for 52.7% of net sales.